Ninety-seven participants of the Triple-Site Versus Standard Cardiac Resynchronization Therapy Trial ( TRUST CRT ) randomized trial , in New York Heart Association class III-IV , QRS width 120 ms , left ventricular ejection fraction 35 % , and significant mechanical dyssynchrony were included .